Pasireotide_Other_Varieties

Name：Pasireotide

Indication：Acromegaly,cushing's disease

CAS No.:396091-73-9

Molecular formula: C58H66N10O9

Pasireotide, sold under the brand name Signifor, is an orphan drug approved in the United States[1] and the European Union[2][3] for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy.[4][5][6] It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.

The most common side effects include hyperglycaemia (high blood sugar levels), diabetes, diarrhoea, abdominal pain (stomach ache), nausea (feeling sick), cholelithiasis (gallstones)

we are cosmetic peptides manufacturer of varieties peptides from china.

https://www.tcspeptides.com/html/product/2020-12-30/51.html